The GSK India product portfolio includes prescription medicines and vaccines. Our prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus and others.
Hypertension or high blood pressure is a blood pressure reading of 140/90 mmHg or higher. Hypertension is usually called a ‘silent killer’ since it usually has no symptoms but is a risk factor for cardiovascular disease, kidney damage and other conditions in the future. If not diagnosed and treated, hypertension could cause heart failure, stroke, kidney failure, aneurysms (bulges in blood vessels) and changes in vision.
We believe that through our business we make a valuable contribution to society by developing and marketing medicines which improve people’s lives. Our philosophy is to target support to selected programs that are innovative, sustainable and which produce tangible results.


This section of our website contains press releases issued and coverage received in India market, presentations made at Analysts meets and a photo library
Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 3500 people. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer. This mission drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions.